Convergen Pharmaceuticals - About the company
Convergen Pharmaceuticals is a seed company based in Suzhou (China), founded in 2020. It operates as a Provider of a platform utilizing Generative AI to accelerate drug discovery and development for the biotech and pharmaceutical industries. Convergen Pharmaceuticals has raised $10M in funding from Qiming Venture Partners. The company has 1982 active competitors, including 452 funded and 333 that have exited. Its top competitors include companies like Antheia, Transcenta and Akeso.
Company Details
Provider of a platform utilizing Generative AI to accelerate drug discovery and development for the biotech and pharmaceutical industries. It utilises the power of Large Language Models specifically trained on biological languages to discover and develop effective drugs.
Key Metrics
Founded Year
2020
Location
Suzhou, China
Stage
Seed
Total Funding
$10M in 1 round
Latest Funding Round
Investors
Ranked
1857th among 1982 active competitors
Sign up to download Convergen Pharmaceuticals' company profile
Convergen Pharmaceuticals's funding and investors
Convergen Pharmaceuticals has raised a total funding of $10M over 1 round. Its latest funding round was a Seed round on Dec 08, 2025 for $*****. 1 investor participated in its latest round. Convergen Pharmaceuticals has 1 institutional investor.
Here is the list of recent funding rounds of Convergen Pharmaceuticals:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 08, 2025 | 9732563 | Seed | 4991426 | 4500286 | 2299207 | 1117403 |
Access funding benchmarks and valuations. Sign up today!View details of Convergen Pharmaceuticals's funding rounds and investors
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Convergen Pharmaceuticals's Competitors and alternates
Top competitors of Convergen Pharmaceuticals include Antheia, Transcenta and Akeso. Here is the list of Top 10 competitors of Convergen Pharmaceuticals, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Antheia 2013, Palo Alto (United States), Series C | Genetically engineered yeast cells to produce medicinal products | $176M | 67/100 | |
2nd | Transcenta 2019, Suzhou (China), Public | Developer of antibody-based therapeutics | $205M | 66/100 | |
3rd | Developer of antibody drug conjugates for the treatment of broad spectrum diseases | $195M | 65/100 | ||
4th | Korro Bio 2018, Cambridge (United States), Public | Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases | $4M | 64/100 | |
5th | Fermentalg 2005, Libourne (France), Public | Innovating with algae for sustainable solutions in nutrition and environmental impact | $30.3M | 63/100 | |
6th | Microban 1994, Huntersville (United States), Acquired | Antimicrobial and odor control technologies for durable product protection and freshness | $64.6M | 63/100 | |
7th | Dewpoint Therapeutics 2018, Boston (United States), Series D | Developer of small molecule based therapeutics | $364M | 62/100 | |
8th | One Biosciences 2020, Paris (France), Series A | Developer of single-cell therapeutics solutions to treat multiple health disorders | $22.4M | 62/100 | |
9th | Developer of oral non-viral gene therapy platform | $54M | 61/100 | ||
10th | Avalyn Pharma 2011, Seattle (United States), Public | Developer of therapies for the treatment of Idiopathic Pulmonary Fibrosis | $389M | 61/100 | |
1857th |  Convergen Pharmaceuticals 2020, Suzhou (China), Seed | Provider of a platform utilizing Generative AI to accelerate drug discovery and development for the biotech and pharmaceutical industries | $10M | 20/100 |
_1523881431192.png?devicePixelRatio=2&height=30&width=30){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Convergen Pharmaceuticals's competitors? Click here to see the top ones
Convergen Pharmaceuticals's Investments and acquisitions
Convergen Pharmaceuticals has made no investments or acquisitions yet.
Reports related to Convergen Pharmaceuticals
Here is the latest report on Convergen Pharmaceuticals's sector:
Are you a Founder ?
FAQs about Convergen Pharmaceuticals
Explore our recently published companies
- Cosmic Roots Astrology - Truckee based, Unfunded company
- Chinom Group - Xuzhou based, Unfunded company
- Pricer - Funding Raised company
- Xinotech Technology - 2021 founded, Unfunded company
- LeadQuity - 2026 founded, Unfunded company
- Simply Lead - Denver based, 2020 founded, Unfunded company
